title: Randomized clinical trials: how long should they last?
authors.forename: Hein J
authors.initials: HJ
authors.lastname: Wellens
mesh_terms: D000638:Amiodarone / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000191:economics / Q000453:epidemiology / Q000209:etiology; D003362:Cost-Benefit Analysis; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control; D017147:Defibrillators, Implantable / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D017180:Tachycardia, Ventricular / Q000150:complications / Q000628:therapy; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000150:complications / Q000628:therapy
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone